Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

maribavir × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Interventions

Rituximab 1395 Cyclophosphamide 1301 Vincristine 668 Doxorubicin 586 Etoposide 528 Prednisone 510 Cytarabine 486 fludarabine 464 Methotrexate 445 Dexamethasone 411 fludarabine phosphate 399 Lenalidomide 354 Filgrastim 343 Bendamustine Hydrochloride 280 Radiotherapy 265 venetoclax 258 ibrutinib 258 obinutuzumab 235 Peripheral Blood Stem Cell Transplantation 234 Melphalan 230 Granulocyte Colony-Stimulating Factor 215 Bortezomib 204 Gemcitabine 200 Whole-Body Irradiation 186 Busulfan 186 Mycophenolic Acid 174 Tacrolimus 164 Specimen Handling 156 Magnetic Resonance Spectroscopy 150 Calcium Dobesilate 150

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07014319 2025-12-04

MALMBA

Seoul National University Hospital

Phase 2 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡